Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 14)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
18-May-13 Pechala's Reports Frantisek Pechala ONCOTHYREON INC (ONTY) 12-months forecast 1 $15 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOTHYREON INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONTY 11 $126.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Oncothyreon Inc 4 $46 View Abstract
10-May-13 Ford Investor Services, Inc. N/A Value Graph: ONCOTHYREON -- ONTY 1 $11.50 View Abstract
10-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: CELG , ENZN , LIFE , ONTY , VRTX -- DRUGS 3 $34.50 View Abstract
9-May-13 Zacks Investment Research Inc. N/A ONCOTHYREON INC (ONTY) Zacks Company Snapshot 1 $11.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
7-May-13 Zacks Investment Research Inc. N/A ONCOTHYREON INC (ONTY) Zacks Company Snapshot 1 $11.50 View Abstract
Next 4

Independent Reports (Showing 1 to 10 of 14)

Release
Date Contributor Author Title Pages Price More Info
18-May-13 Pechala's Reports Frantisek Pechala ONCOTHYREON INC (ONTY) 12-months forecast 1 $15 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOTHYREON INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONTY 11 $126.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Oncothyreon Inc 4 $46 View Abstract
10-May-13 Ford Investor Services, Inc. N/A Value Graph: ONCOTHYREON -- ONTY 1 $11.50 View Abstract
10-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: CELG , ENZN , LIFE , ONTY , VRTX -- DRUGS 3 $34.50 View Abstract
9-May-13 Zacks Investment Research Inc. N/A ONCOTHYREON INC (ONTY) Zacks Company Snapshot 1 $11.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
7-May-13 Zacks Investment Research Inc. N/A ONCOTHYREON INC (ONTY) Zacks Company Snapshot 1 $11.50 View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.